Private equity firms TowerBrook Capital Partners and Clayton, Dubilier & Rice are teaming up to buy healthcare billing company R1 RCM, with a valuation of $8.9 billion. TowerBrook already owns 36% of R1, making them the largest shareholder. The acquisition marks the end of a bidding war for R1, highlighting private equity’s interest in revenue cycle management companies that handle medical billing, collections, and administrative services for healthcare providers. This move takes R1 off the public markets, ending a months-long saga between private equity firms vying for control of the company.
Source link
PE firms strike $8.9 billion deal for health care billing firm R1 RCM
